Literature DB >> 8624774

Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis.

K D O'Brien1, D D Reichenbach, S M Marcovina, J Kuusisto, C E Alpers, C M Otto.   

Abstract

Nonrheumatic aortic stenosis of trileaflet aortic valves has been considered to be a "degenerative" process, but the early lesion of aortic stenosis contains the chronic inflammatory cells, macrophages and T lymphocytes. Because lipoprotein deposition is prominent in atherosclerosis, another chronic inflammatory process, this study examined whether lipoproteins accumulate in aortic valve lesions. Immunohistochemical studies were performed to detect apolipoprotein (apo) B, apo(a), apoE, macrophages, and alpha-actin-expressing cells on 18 trileaflet aortic valves that ranged from normal to stenotic. All three apolipoproteins were detected in early through end-stage lesions of aortic stenosis but not in histologically normal regions. Comparison with oil red O staining suggested that most of the extracellular neutral lipid in these valves was associated with either plasma-derived or locally produced apolipoproteins. Thus, in early through end-stage aortic valve lesions, apolipoproteins accumulate and are associated with the majority of extracellular valve lipid. These results are consistent with the hypothesis that lipoprotein accumulation in the aortic valve contributes to pathogenesis of aortic stenosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624774     DOI: 10.1161/01.atv.16.4.523

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  132 in total

1.  Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation.

Authors:  Joanna Luszczak; Anetta Undas; Matthew Gissel; Maria Olszowska; Saulius Butenas
Journal:  Blood Coagul Fibrinolysis       Date:  2011-09       Impact factor: 1.276

Review 2.  Calcific aortic stenosis: from bench to the bedside--emerging clinical and cellular concepts.

Authors:  Nalini M Rajamannan; Bernard Gersh; Robert O Bonow
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

3.  Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: an angiographic pair matched case-control study.

Authors:  J R Ortlepp; F Schmitz; T Bozoglu; P Hanrath; R Hoffmann
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

4.  Calcification of bicuspid aortic valves.

Authors:  C M Otto
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

5.  Targeted therapy to prevent progression of calcific aortic stenosis.

Authors:  Nalini M Rajamannan; Catherine M Otto
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

6.  Aortic stenosis: An update.

Authors:  Sangeetha Nathaniel; Shreyas Saligram; Antony Leslie Innasimuthu
Journal:  World J Cardiol       Date:  2010-06-26

7.  T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves.

Authors:  L Wallby; B Janerot-Sjöberg; T Steffensen; M Broqvist
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

8.  Decorin and biglycan retain LDL in disease-prone valvular and aortic subendothelial intimal matrix.

Authors:  Edward B Neufeld; Leah M Zadrozny; Darci Phillips; Angel Aponte; Zu-Xi Yu; Robert S Balaban
Journal:  Atherosclerosis       Date:  2014-01-08       Impact factor: 5.162

Review 9.  Imaging of inflammation and calcification in aortic stenosis.

Authors:  Marc R Dweck; Nikhil V Joshi; James H F Rudd; David E Newby
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

Review 10.  Selection of artificial valve for the patients on hemodialysis.

Authors:  Hirofumi Takemura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.